Project dates: March 2020 - August 2021
This study used semi-structured interviews with key stakeholders in Medication for the Treatment of Opioid Use Disorder, to examine potential differences across treatment modalities (e.g., MMT vs. buprenorphine, clinic-based vs. office-based), and among individual treatment programs/providers (e.g., abstinence-based vs. harm reduction), in how these different approaches function in regards to patient satisfaction, and uptake of and retention in, Medication for the Treatment of Opioid Use Disorder. Findings will be used to to establish feasibility and informing the development of more specific research questions and/or hypotheses and appropriate research design to address them.
“It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives
Harm Reduction Journal, 18 (1), 88. doi: 10.1186/s12954-021-00535-y. PMCID: PMC8364307.